The RAC25 Conference in Amsterdam was an excellent opportunity for us to deepen our knowledge, network with experts, and stay on top of the latest trends in regulatory affairs and compliance within the generic pharmaceutical industry. The event offered a wide range of topics, addressing both current challenges and upcoming changes in the regulatory environment, at both the EU level and globally. It was a unique chance to get a comprehensive view of the evolving regulatory landscape and how it will shape the future of the industry.
The discussions on the revised pharmaceutical legislation, the role of digitalization in the regulatory process, and environmental risk assessments (ERA) stood out to us as some of the most impactful topics. These discussions provided us with a better understanding of the changes that will influence our work in the coming years. It was inspiring to see the industry’s commitment to adapting to new regulatory demands while maintaining high standards of safety and efficacy.
At our booth, the topics that sparked the most interest among visitors were regulatory strategy and due diligence, environmental risk assessment, electronic product information, pharmacovigilance, medical devices, toxicology, etc. These are areas where we see a growing need for expert support, and the conference gave us valuable insights into the best practices and strategies to help our clients navigate these complex processes.
Beyond the presentations, the conference also provided a fantastic opportunity to connect with both existing and potential business partners. We were able to establish new relationships, exchange experiences, and open the door to future collaborations. The opportunity to engage with industry peers and share knowledge was incredibly valuable, and we look forward to the potential for new partnerships that may arise from these interactions.
Looking back, the RAC25 Conference offered us a wealth of useful information and fresh ideas that we are eager to incorporate into our work. It was truly inspiring to witness the industry’s evolution firsthand and to see how critical it is to adapt to new regulatory requirements. The conference reinforced our belief in the importance of staying proactive and prepared for the changes ahead.
